Featured Jobs
|
BPAS
|
|
MAP Retirement
|
|
DWC - The 401(k) Experts
|
|
Retirement Relationship Manager MAP Retirement
|
|
Plan Administrator, Defined Benefit & Cash Balance The Pension Source
|
|
Regional Vice President, Sales MAP Retirement
|
|
Strategic Retirement Plan Consultant Retirement Plan Consultants
|
|
Pattison Pension
|
|
MAP Retirement
|
|
Defined Benefit Plan Consultant/Actuarial Analyst Sentinel Group
|
|
Sentinel Group
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Navigating the New Landscape: Critical Pharmacy Benefit Trends Employers Must Understand (PDF)
EPIC Brokers; registration may be required 
Dec. 11, 2024 "69% of employers see [cell and gene therapy (CGT)] affordability as a moderate or major challenge ... 32% of employers are confident in their understanding of the financial impact of CGTs ... Three-quarters of employers are moderately or very concerned about affordability of GLP-1s, and that same proportion have experienced increased GLP-1 spend ... [E]mployers are showing their declining satisfaction with their PBMs through lower willingness to recommend their PBM to others." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |